CRISPR Therapeutics Earnings Update: Maintains The Lead In Cas9 Clinical Trials – Seeking Alpha
|
CRISPR Therapeutics Earnings Update: Maintains The Lead In Cas9 Clinical Trials
Seeking Alpha CRSP's update on their pipeline is encouraging – IND on track for 2017, first company in the CRISPR-Cas9 clinical space. Looking to address a large market with their lead product in ß-thallasemia and Sickle Cell Disease. Continuing to pay attention to … Head to Head Comparison: Crispr Theraptc (CRSP) and Editas Medicine (EDIT) CRISPR THERAPTC (CRSP) Announces Earnings Results CRISPR Therapeutics AG (NasdaqGM:CRSP): A Look at Technicals & Valuation |
